Hims & Hers Replaces Eucalyptus in Australian Women's Health

Hims & Hers Health, a prominent US telehealth provider, has expanded its reach into Australia with its women's health brand, Hers. This launch effectively retires Juniper, a weight-loss service that Sydney-based Eucalyptus introduced in 2021. This strategic shift is the culmination of Hims & Hers' $1.6 billion acquisition of Eucalyptus earlier this year, after which Eucalyptus' men's health brand, Pilot, was integrated into Hims in August. The new Hers clinic will offer expanded services, including programs for hair loss and menopause, moving beyond Juniper's historical focus on weight management.

Existing patients under Juniper will maintain continuity of care, keeping their Australian practitioners, care teams, treatment plans, and pricing. The integration promises to leverage Hims & Hers' technological capabilities, including AI-driven health coaching and care management tools, which are already being implemented in the Australian business. A new Hers app will be available to Australian customers starting today. Prescriptions for TGA-approved weight-loss drugs like Wegovy and Mounjaro will be available, with monthly programs starting at $349, alongside dedicated menopause and hair loss programs.

The transition also addresses regulatory landscapes. While Australia prohibits direct advertising of prescription medicines to the public, Hers plans to focus on educating women about their symptoms. The Royal Australian College of General Practitioners has raised concerns about subscription telehealth services prioritizing financial returns over patient safety, advocating for comprehensive care from established GPs. Hims & Hers acknowledges the emerging grey market in digital health and anticipates national telehealth standards within the next twelve months.